Receptor Stories

G.I. JOE is the code name for America's daring, highly-trained special mission force. Its purpose: to defend human freedom against Cobra, a ruthless terrorist organization determined to rule the world. Now the new generation of Joes will join hands with the Autobots from Cybertron and battle Cobra's new Decepticon Armada.

In 2022, the global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market was valued at US$ 2.54 billion, and is poised for substantial growth. Forecasts predict that the market will expand to US$ 3.5 billion by 2023 and is projected to reach an impressive US$ 6.82 billion by 2033, maintaining a steady CAGR of 6.9% from 2023 onwards. This remarkable trajectory is primarily attributed to advancements in technology and the escalating demand for personalized treatment options. Notably, from 2018 to 2022, the CAR T-cell therapy market witnessed a robust growth at a CAGR of 7%.